3-pyridin-2-yl-4,5-dihydroisoxazole-5-carboxylic acid | 396726-64-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 3-pyridin-2-yl-4,5-dihydroisoxazole-5-carboxylic acid
• 英文别名: 3-pyridin-2-yl-4,5-dihydro-1,2-oxazole-5-carboxylic acid
• CAS: 396726-64-0
• 化学式: C₉H₈N₂O₃
• 分子量: 192.174
• InChiKey: RKEQTVJMWSCNBP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  71.8
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  3-pyridin-2-yl-4,5-dihydroisoxazole-5-carboxylic acid 、 (S)-N-((3-(3-氟-4-(哌嗪-1-基)苯基)-2-氧代噁唑啉-5-基)甲基)乙酰胺 在 1-羟基苯并三唑 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 、 三乙胺 作用下， 以 二氯甲烷 为溶剂， 以69%的产率得到N-(3-{3-fluoro-4-[4-(3-pyridin-2-yl-4,5-dihydro-isoxazole-5-carbonyl)-piperazin-1-yl]-phenyl}-2-oxo-oxazolidin-5-ylmethyl)-acetamide
  参考文献：
  名称：

  Synthesis and antibacterial evaluation of isoxazolinyl oxazolidinones: Search for potent antibacterial

  摘要：

  A series of (5S) N-(3-{3-fluoro-4-[4-(3-aryl-4,5-dihydro-isoxazole-5-carbonyl)-piperazin-1-yl]-phenyl}2-oxo-oxazolidin-5-ylmethyl)-acetamide(6a-o) were synthesized and their in vitro antibacterial activity against various resistant Gram-positive and Gram-negative bacteria were evaluated. Most of the synthesized compounds showed 2 to 10 fold lower MIC values compared to linezolid against Staphylococcus aureus ATCC 25923, ATCC 70069, ATCC 29213, Bacillus cereus MTCC 430, Enterococcus faecalis MTCC439, Klebsiella pneumoniae ATCC 27736, and Streptococcus pyogens. (C) 2009 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2009.04.133
• 作为产物：
  描述：

  ethyl 3-(pyridin-2-yl)-4,5-dihydroisoxazole-5-carboxylate 在 水 、 lithium hydroxide 作用下， 以 四氢呋喃 、 甲醇 为溶剂， 生成 3-pyridin-2-yl-4,5-dihydroisoxazole-5-carboxylic acid
  参考文献：
  名称：

  Synthesis and antibacterial evaluation of isoxazolinyl oxazolidinones: Search for potent antibacterial

  摘要：

  A series of (5S) N-(3-{3-fluoro-4-[4-(3-aryl-4,5-dihydro-isoxazole-5-carbonyl)-piperazin-1-yl]-phenyl}2-oxo-oxazolidin-5-ylmethyl)-acetamide(6a-o) were synthesized and their in vitro antibacterial activity against various resistant Gram-positive and Gram-negative bacteria were evaluated. Most of the synthesized compounds showed 2 to 10 fold lower MIC values compared to linezolid against Staphylococcus aureus ATCC 25923, ATCC 70069, ATCC 29213, Bacillus cereus MTCC 430, Enterococcus faecalis MTCC439, Klebsiella pneumoniae ATCC 27736, and Streptococcus pyogens. (C) 2009 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2009.04.133

文献信息

• Hexahydropyridazine-3-carboxylic acid derivatives, pharmaceutical compositions containing same and methods of preparation
  申请人：Bhatnagar Neerja

  公开号：US20050171346A1

  公开（公告）日：2005-08-04

  The present invention discloses and claims compounds of formula (I) as inhibitors of proteases and kinases, method using said compounds of formula (I) for the prevention or treatment of certain cardiovascular, central nervous system, inflammatory, and bone diseases as well as infectious diseases and certain cancers. Combinatorial libraries of compounds of formula (I), pharmaceutical compositions and methods for preparation of combinatorial libraries and compounds of formula (I) are also disclosed and claimed.

  本发明揭示和声明了化合物的公式(I)作为蛋白酶和激酶的抑制剂，以及使用该化合物的方法，用于预防或治疗某些心血管、中枢神经系统、炎症、骨骼疾病以及传染病和某些癌症。还揭示和声明了化合物的公式(I)的组合库、制药组合物以及制备组合库和化合物的方法。
• US7034022B2
  申请人：——

  公开号：US7034022B2

  公开（公告）日：2006-04-25